| 5908- | CAR, | Carvacrol improves neurological function by inhibiting TRPM7-mediated BBB disruption and hemorrhage after TBI |
| - | in-vivo, | Nor, | NA |
| 5909- | CAR, | Potential preventive effect of carvacrol against diethylnitrosamine-induced hepatocellular carcinoma in rats |
| 5910- | CAR, | Oregano Phytocomplex Induces Programmed Cell Death in Melanoma Lines via Mitochondria and DNA Damage |
| - | in-vitro, | Melanoma, | B16-F10 | - | NA, | NA, | A375 |
| 5896- | CAR, | TV, | Carvacrol and Thymol Hybrids: Potential Anticancer and Antibacterial Therapeutics |
| - | Review, | Var, | NA |
| 5905- | CAR, | HCQ, | Synergistic inhibition of metastatic melanoma by carvacrol and chloroquine: an in vitro and in silico investigation of apoptosis and molecular targets |
| - | in-vitro, | Melanoma, | NA |
| 5903- | CAR, | TV, | Combined Cytotoxic Effects of Carvacrol-Based Essential Oil Formulations |
| - | in-vitro, | BC, | MDA-MB-231 |
| 5902- | CAR, | A novel antagonist of TRPM2 and TRPV4 channels: Carvacrol |
| - | in-vitro, | Nor, | HEK293 |
| 5901- | CAR, | Neuroprotective role of carvacrol in ischemic brain injury: a systematic review of preclinical evidence and proposed TRPM7 involvement |
| - | Review, | Stroke, | NA |
| 5900- | CAR, | TV, | Lights and Shadows of Essential Oil-Derived Compounds: Antimicrobial and Anti-Inflammatory Properties of Eugenol, Thymol, Cinnamaldehyde, and Carvacrol |
| - | Review, | Nor, | NA |
| - | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | MDA-MB-231 |
| 5898- | CAR, | Carvacrol-induced apoptosis via tumor suppressor gene activation and oxidative stress modulation in a rat model of breast cancer |
| - | in-vivo, | BC, | NA |
| 5897- | CAR, | Carvacrol Selectively Induces Mitochondria-Related Apoptotic Signaling in Primary Breast Cancer-Associated Fibroblasts |
| - | in-vitro, | BC, | NA |
| 5906- | CAR, | Screening and Validation of a Carvacrol-Targeting Viability-Regulating Protein, SLC6A3, in Liver Hepatocellular Carcinoma |
| - | in-vitro, | HCC, | NA |
| 5895- | CAR, | Carvacrol as a Therapeutic Candidate in Breast Cancer: Insights into Subtype-Specific Cellular Modulation |
| - | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | MDA-MB-231 |
| 5894- | CAR, | Targeting Gastrointestinal Cancers with Carvacrol: Mechanistic Insights and Therapeutic Potential |
| - | Review, | Var, | NA |
| 5893- | CAR, | TV, | Thymol and Carvacrol: Molecular Mechanisms, Therapeutic Potential, and Synergy With Conventional Therapies in Cancer Management |
| - | Review, | Var, | NA |
| 5892- | CAR, | SRF, | Carvacrol potentiates immunity and sorafenib anti-cancer efficacy by targeting HIF-1α/STAT3/ FGL1 pathway: in silico and in vivo study |
| - | in-vivo, | HCC, | NA |
| 5891- | CAR, | SRF, | Carvacrol enhances anti-tumor activity and mitigates cardiotoxicity of sorafenib in thioacetamide-induced hepatocellular carcinoma model through inhibiting TRPM7 |
| - | in-vivo, | HCC, | NA |
| 5890- | CAR, | Carvacrol as a Prospective Regulator of Cancer Targets/Signalling Pathways |
| - | Review, | Var, | NA |
| 5889- | CAR, | Effect of carvacrol on pulmonary function tests, and total and differential white blood cell counts in healthy volunteers: A randomized clinical trial |
| - | Trial, | Nor, | NA |
| 5912- | CAR, | Inhibition of TRPM7 by carvacrol suppresses glioblastoma cell proliferation migration and invasion |
| - | in-vitro, | GBM, | U87MG | - | in-vitro, | Nor, | HEK293 |
| 5927- | CAR, | Neuroprotective Potential and Underlying Pharmacological Mechanism of Carvacrol for Alzheimer’s and Parkinson’s Diseases |
| - | Review, | AD, | NA | - | Review, | Park, | NA |
| 5926- | CAR, | An Updated Review of Research into Carvacrol and Its Biological Activities |
| - | Review, | Nor, | NA | - | Review, | AD, | NA | - | Review, | asthmatic, | NA |
| 5925- | CAR, | Neuroprotective effects of carvacrol against Alzheimer’s disease and other neurodegenerative diseases: A review |
| - | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
| 1082- | CAR, | Carvacrol, a component of thyme oil, activates PPARα and γ and suppresses COX-2 expression |
| - | in-vitro, | lymphoma, | U937 |
| - | in-vitro, | Kidney, | HK-2 |
| 1287- | CAR, | Carvacrol induces apoptosis in human breast cancer cells via Bcl-2/CytC signaling pathway |
| - | in-vitro, | BC, | HCC1937 |
| 5862- | carbop, | Cisplatin, | Molecular Mechanisms of Resistance and Toxicity Associated with Platinating Agents |
| - | Review, | Var, | NA |
| 5863- | carbop, | Rad, | Carboplatin as a potentiator of radiation therapy |
| - | vitro+vivo, | Lung, | NA |
| 3876- | Carno, | Ex, | Swimming exercise versus L-carnosine supplementation for Alzheimer’s dementia in rats: implication of circulating and hippocampal FNDC5/irisin |
| - | in-vivo, | AD, | NA |
| - | in-vitro, | AD, | NA |
| 3874- | Carno, | Effects of zinc and carnosine on aggregation kinetics of Amyloid-β40 peptide |
| - | Review, | AD, | NA |
| 3877- | Carno, | Carnosine, diabetes and Alzheimer's disease |
| - | Review, | AD, | NA |
| 3878- | Carno, | Safety and Efficacy Evaluation of Carnosine, An Endogenous Neuroprotective Agent for Ischemic Stroke |
| - | in-vivo, | Stroke, | NA |
| 3879- | Carno, | Daily Carnosine and Anserine Supplementation Alters Verbal Episodic Memory and Resting State Network Connectivity in Healthy Elderly Adults |
| - | Human, | AD, | NA |
| 3873- | Carno, | Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice |
| - | in-vivo, | AD, | NA |
| 3871- | Carno, | Unveiling the Hidden Therapeutic Potential of Carnosine, a Molecule with a Multimodal Mechanism of Action: A Position Paper |
| - | Review, | NA, | NA |
| 3870- | Carno, | Could carnosine or related structures suppress Alzheimer's disease? |
| - | Review, | AD, | NA |
| 3880- | Carno, | EFFECT OF ANSERINE/CARNOSINE SUPPLEMENTATION ON THE PREVENTION OF ALZHEIMER'S DISEASE IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT |
| - | Trial, | AD, | NA |
| 3881- | Carno, | The Therapeutic Potential of Carnosine/Anserine Supplementation against Cognitive Decline: A Systematic Review with Meta-Analysis |
| - | Review, | AD, | NA |
| 3872- | Carno, | Carnosine Protects Macrophages against the Toxicity of Aβ1-42 Oligomers by Decreasing Oxidative Stress |
| - | in-vitro, | AD, | NA |
| 3869- | Carno, | Carnosine, Small but Mighty—Prospect of Use as Functional Ingredient for Functional Food Formulation |
| - | Review, | AD, | NA | - | Review, | Stroke, | NA |
| 5930- | Catechins, | Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention |
| - | Trial, | Pca, | NA |
| 5929- | Catechins, | Phase I trial of oral green tea extract in adult patients with solid tumors |
| - | Trial, | Var, | NA |
| 5928- | Catechins, | Bioavailability of Tea Catechins and Its Improvement |
| - | Review, | Nor, | NA |
| 603- | Catechins, | Catechins induce oxidative damage to cellular and isolated DNA through the generation of reactive oxygen species |
| - | in-vitro, | NA, | HL-60 |
| 939- | Catechins, | 5-FU, | Targeting Lactate Dehydrogenase A with Catechin Resensitizes SNU620/5FU Gastric Cancer Cells to 5-Fluorouracil |
| - | vitro+vivo, | GC, | SNU620 |
| 5921- | Cats, | Effect of Uncaria tomentosa Extract on Apoptosis Triggered by Oxaliplatin Exposure on HT29 Cells |
| - | in-vitro, | Colon, | HT29 |
| 5922- | Cats, | Uncaria tomentosa acts as a potent TNF-α inhibitor through NF-κB |
| - | in-vitro, | AML, | THP1 |
| 5920- | Cats, | Treatment with Uncaria tomentosa Promotes Apoptosis in B16-BL6 Mouse Melanoma Cells and Inhibits the Growth of B16-BL6 Tumours |
| - | in-vivo, | Melanoma, | B16-BL6 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid